tiprankstipranks
Intra-Cellular Therapies (ITCI)
NASDAQ:ITCI

Intra-Cellular Therapies (ITCI) Similar Stocks

791 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Intra-Cellular Therapies
$6.38B
-45.18
4.27%
10 Buy
1 Hold
0 Sell
Strong Buy
premium
Alkermes
$4.01B
11.80
-10.78%
5 Buy
5 Hold
1 Sell
Moderate Buy
premium
Avadel Pharmaceuticals
$1.52B
-7.90
58.63%
8 Buy
0 Hold
0 Sell
Strong Buy
premium
Axsome Therapeutics
$3.28B
-13.30
-1.86%
13 Buy
1 Hold
0 Sell
Strong Buy
premium
ACADIA Pharmaceuticals
$2.82B
-45.08
-11.51%
13 Buy
5 Hold
0 Sell
Moderate Buy
premium

Performance Comparison

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis